Oslo, Norway, 20 May 2021
Vistin Pharma ASA (OSE: VISTIN), please find attached the minutes from the annual general meeting held on 20 May 2021. All matters were resolved as proposed in the call for the annual general meeting.
For further information, please contact:
+47 97 05 36 21
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.